Gapping down
In reaction to earnings/guidance:
- PINS -11.6%, ENPH -8.5%, SPOT -7.5%, DISCA -6.8%, FFIV -5%, USNA -4.5%, AMGN -4.1%, FCPT -4%, RRD -3.7%, TXN -3.1%, SYK -3%, ADP -3%, MSFT -2.7%, SHOO -2.7%, EQR -2%, MRC -2%, NOV -1.9%, SBUX -1.6%, HELE -1.6%, OKE -1.3%, SIRI -1.3%, TEVA -1.2%, BA -1%
Other news:
- PLX -43.2% (receives Complete Response Letter for Pegunigalsidase Alfa from FDA)
- BIVI -17.7% (to acquire biopharma assets from NeurMedix)
- DMTK -7.7% (to collaborate on longitudinal study on hidradenitis suppurativa)
- CMPS -6.4% (files for 4 mln ADS offering)
- NGVT -5.2% (announces partnership with and investment in GreenGasUSA)
- FOA -4.9% (to acquire certain assets of Parkside Lending for $40 mln)
- ALDX -4.6% (stock offering)
- SAVE -3.6% (convertible notes offering)
- PRVB -3% (took part in FDA meeting in connection with the FDA's ongoing review of the teplizumab BLA)
- BE -1.1% (announces successful deployment of first fuel cells powered solely by hydrogen)
Analyst comments:
- FSLY -3.3% (downgraded to Mkt Perform from Outperform at Raymond James)
- CLLS -2.2% (downgraded to Neutral from Buy at Guggenheim)
- HLX -2.1% (downgraded to Neutral from Buy at BofA Securities)